Drug Type Small molecule drug |
Synonyms (Z)-Capsaicin, Civamide, Civanex + [6] |
Target |
Action agonists |
Mechanism TRPV1 agonists(Vanilloid receptor agonists) |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhaseApproved |
First Approval Date Canada (15 Jul 2010), |
RegulationOrphan Drug (United States) |
Molecular FormulaC18H27NO3 |
InChIKeyYKPUWZUDDOIDPM-VURMDHGXSA-N |
CAS Registry25775-90-0 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
D06388 | Zucapsaicin |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Osteoarthritis | Canada | - | 15 Jul 2010 |
Pain | Canada | - | 15 Jul 2010 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Trigeminal Neuralgia | Phase 1 | United States | 01 Mar 2014 | |
Neuralgia, Postherpetic | Phase 1 | United States | 01 Mar 2009 | |
Neuralgia, Postherpetic | Phase 1 | Canada | 01 Mar 2009 | |
Dry Eye Syndromes | Discovery | United States | 01 May 2014 | |
Neuralgia, Postherpetic | Discovery | United States | 01 Mar 2009 | |
Neuralgia, Postherpetic | Discovery | Canada | 01 Mar 2009 | |
Post-traumatic neuralgia | Discovery | Canada | 01 Mar 2009 | |
Post-traumatic neuralgia | Discovery | United States | 01 Mar 2009 | |
Osteoarthritis, Knee | Discovery | - | 01 Jun 2003 | |
Cluster Headache | Discovery | United States | 01 Jan 2002 |
Phase 2 | 232 | ziqaxnkkpm(alnlgaukdr) = ddhpybfuvj avpxsqyevm (xixxdtnqal, bagwqyvvdx - jemaapmogs) View more | - | 01 Dec 2023 | |||
Phase 2 | 63 | Combination pharmacotherapy - transdermal nicotine patch + nicotine gum+Bupropion Sustained Release+Nicotine replacement therapy - nicotine gum+Varenicline+Nicotine replacement therapy - transdermal nicotine patch (Tailored Intervention Group) | gfohphvwjv(nqpdkpgouj) = lugmhqebxn oiiqbvlhqz (vqtptpeyxy, loqqgkkbis - hkvsnqhjoj) View more | - | 19 Jul 2017 | ||
Combination pharmacotherapy - transdermal nicotine patch + nicotine gum+Bupropion Sustained Release+Nicotine replacement therapy - nicotine gum+Varenicline+Nicotine replacement therapy - transdermal nicotine patch (Enhanced Standard of Care Group) | gfohphvwjv(nqpdkpgouj) = mlldffsqey oiiqbvlhqz (vqtptpeyxy, grtluvfged - deiufpoyma) View more | ||||||
Phase 2 | 11 | (Double Blind Treatment Period Civamide Nasal Spray) | zgzlniloru(rtpxiulwjp) = qgeiniybnu kjzqkmulzx (kupqifiaqh, rsyogcuzpy - fgiobxakyt) View more | - | 01 Mar 2017 | ||
Placebo (Double Blind Treatment Period Placebo Nasal Spray) | zgzlniloru(rtpxiulwjp) = gcykvrgszy kjzqkmulzx (kupqifiaqh, smuphizoaq - htqsoehqsv) View more |